Picard Medical, INC. (PMI) — SEC Filings

Q: What are the key financial highlights for Picard Medical, INC.?

Key financial highlights for Picard Medical, INC. are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Picard Medical, INC.?

Key executives at Picard Medical, INC. are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Picard Medical, INC. stock?

Risk factors for Picard Medical, INC. (PMI) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Picard Medical, INC.?

Forward-looking statements and predictions from Picard Medical, INC. are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Picard Medical, INC.. Recent 8-K filing on Apr 22, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Picard Medical, INC. on SEC EDGAR

Overview

Picard Medical, INC. (PMI) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Apr 22, 2026: Picard Medical, Inc. filed an 8-K report on April 22, 2026, detailing its financial results and condition. The filing includes financial statements and exhibits, with the primary focus on Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). The

Sentiment Summary

Across 26 filings, the sentiment breakdown is: 2 bearish, 22 neutral, 2 mixed. The dominant filing sentiment for Picard Medical, INC. is neutral.

Filing Type Overview

Picard Medical, INC. (PMI) has filed 14 8-K, 1 10-K, 2 10-Q, 1 DEF 14A, 7 S-1/A, 1 S-1 with the SEC between Apr 2025 to Apr 2026.

Filings by Year

2026 · 2025

Recent Filings (26)

Picard Medical Files 8-K on Financials — 8-K · Apr 22, 2026 Risk: low
Picard Medical, Inc. filed an 8-K report on April 22, 2026, detailing its financial results and condition. The filing includes financial statements and exhibits
Picard Medical Eyes Next-Gen Heart, Faces Going Concern Warning — 10-K · Mar 30, 2026 Risk: high
Picard Medical, Inc. (PMI) filed its 10-K for the fiscal year ended December 31, 2025, detailing its operations as a holding company for SynCardia Systems, LLC.
Picard Medical Files 8-K on Financial Results, Exhibits — 8-K · Mar 25, 2026
Picard Medical, Inc. filed an 8-K on March 25, 2026, disclosing its results of operations and financial condition under Item 2.02. This filing also included fin
8-K Filing — 8-K · Dec 30, 2025
8-K Filing — 8-K · Dec 18, 2025
Picard Medical Files 8-K — 8-K · Dec 9, 2025 Risk: low
On December 9, 2025, Picard Medical, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No
8-K Filing — 8-K · Dec 4, 2025
Picard Medical Files 8-K Report — 8-K · Dec 3, 2025 Risk: low
On December 3, 2025, Picard Medical, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. No spe
8-K Filing — 8-K · Nov 26, 2025
8-K Filing — 8-K · Nov 19, 2025
8-K Filing — 8-K · Nov 14, 2025
Picard Medical's Losses Mount Amid Soaring Interest, Derivative Costs — 10-Q · Nov 14, 2025 Risk: high
Picard Medical, Inc. (PMI) reported a net loss of $22.711 million for the nine months ended September 30, 2025, a significant increase from the $12.217 million
Picard Medical, Inc. Files 8-K Report — 8-K · Oct 27, 2025 Risk: low
On October 24, 2025, Picard Medical, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and includes financial statements and exh
Picard Medical Files 8-K on Shareholder Votes and Financials — 8-K · Oct 14, 2025 Risk: low
Picard Medical, Inc. filed an 8-K on October 14, 2025, reporting on matters submitted to a vote of security holders and financial statements. The earliest event
Picard Medical Seeks Shareholder Nod for Expanded Equity Plan — DEF 14A · Sep 29, 2025 Risk: medium
Picard Medical, Inc. (PMI) is seeking stockholder approval to amend its 2021 Equity Incentive Plan, increasing the aggregate number of shares available to a tot
Picard Medical's Losses Double Amid Soaring Interest, Derivative Costs — 10-Q · Sep 12, 2025 Risk: high
Picard Medical, Inc. (PMI) reported a significant increase in net loss for the six months ended June 30, 2025, reaching $12.285 million, a substantial rise from
Picard Medical Files 8-K Report — 8-K · Sep 10, 2025 Risk: low
On September 9, 2025, Picard Medical, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no sp
Picard Medical Announces Board Changes and Agreements — 8-K · Sep 4, 2025 Risk: medium
Picard Medical, Inc. announced on August 28, 2025, several key events including entering into a material definitive agreement, the departure of directors and of
Picard Medical Files S-1/A Amendment 7, Nears IPO Launch — S-1/A · Aug 6, 2025 Risk: high
Picard Medical, Inc. (PMI) filed Amendment No. 7 to its S-1 Registration Statement on August 6, 2025, indicating its status as a Smaller Reporting Company and a
Picard Medical Files S-1/A, Nears Public Offering — S-1/A · Jul 30, 2025 Risk: medium
Picard Medical, Inc. filed Amendment No. 6 to its S-1 Registration Statement on July 30, 2025, indicating its intent to commence a public sale of securities as
Picard Medical Amends S-1 for IPO, Eyes Public Debut — S-1/A · Jul 18, 2025 Risk: high
Picard Medical, Inc. (PMI) filed an S-1/A on July 18, 2025, as Amendment No. 5 to its initial S-1 registration statement, indicating its intent to commence a pu
Picard Medical Files S-1/A, Nears IPO Launch — S-1/A · Jul 14, 2025 Risk: medium
Picard Medical, Inc. (PMI) filed an S-1/A on July 14, 2025, as Amendment No. 4 to its S-1 Registration Statement, indicating its intent to commence a public sal
Picard Medical Files S-1/A Amendment 3, Nears IPO Launch — S-1/A · May 23, 2025 Risk: medium
Picard Medical, Inc. (PMI) filed an S-1/A on May 23, 2025, as Amendment No. 3 to its initial S-1 registration statement, indicating its intent to commence a pub
Picard Medical Files S-1/A for IPO — S-1/A · May 9, 2025 Risk: medium
Picard Medical, Inc. filed an S-1/A amendment on May 9, 2025, for its initial public offering. The company, incorporated in Delaware, is seeking to register its
Picard Medical Files S-1/A for IPO — S-1/A · Apr 25, 2025 Risk: medium
Picard Medical, Inc. filed an S-1/A amendment on April 25, 2025, for its initial public offering. The company, incorporated in Delaware, is based in Tucson, AZ,
Picard Medical Files for IPO — S-1 · Apr 1, 2025 Risk: medium
Picard Medical, Inc. filed an S-1 registration statement with the SEC on March 31, 2025, to register its securities for public offering. The company, incorporat

Risk Profile

Risk Assessment: Of PMI's 19 recent filings, 5 were flagged as high-risk, 8 as medium-risk, and 6 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Key Executives

Patrick NJ Schnegelsberg
Bernard Skaggs
Matt Schuster
Michael J. Blankenship
Beniamin D. Smolij
Richard A. Friedman, Esq.
Sean F. Reid, Esq.
Emily Mastoloni Esq.

Industry Context

Picard Medical operates in the highly specialized and regulated medical device market for advanced cardiac support. The Total Artificial Heart (TAH) segment is characterized by high barriers to entry due to complex technology, extensive clinical validation, and stringent regulatory approvals. Key trends include the development of smaller, fully implantable devices and expanding indications for mechanical circulatory support to improve patient outcomes and quality of life.

Top Tags

Medical Devices (8) · IPO (6) · SEC Filing (6) · sec-filing (5) · S-1/A (5) · Emerging Growth Company (5) · 8-k (4) · Tucson AZ (4) · medical-devices (3) · Going Concern (3)

Key Numbers

Aggregate market value of common stock held by non-affiliates: $130,820,904 — As of September 2, 2025, the IPO closing date
Common shares outstanding: 75,178,535 — As of March 23, 2026
Gross proceeds from IPO: $19.6 million — From 4,887,500 shares at $4.00 per share in September 2025
Net proceeds from IPO: $15.2 million — After underwriting discounts and commissions
Repayment of Senior Secured Notes and related party working capital loans: $8.2 million — Using net proceeds from IPO
SynCardia TAHs implanted: 2,100 — Across 27 countries to date
Earliest potential FDA approval for Emperor TAH: 2028 — Subject to nonclinical testing and regulatory review
Shares sold in IPO: 4,887,500 — Including over-allotment options
Public offering price per share: $4.00 — For the September 2025 IPO
Countries with SynCardia TAH implants: 27 — Demonstrating international reach
Net Loss: $22.711M — for the nine months ended September 30, 2025, up from $12.217M in 2024
Total Revenues: $3.931M — for the nine months ended September 30, 2025, up from $3.555M in 2024
Derivative Loss: $7.040M — for the nine months ended September 30, 2025, significantly up from $441K in 2024
Interest Expense: $5.386M — for the nine months ended September 30, 2025, up from $1.636M in 2024
Cash and Cash Equivalents: $2.813M — as of September 30, 2025, up from $96K at December 31, 2024

Related Companies

ABT · CRMT

Frequently Asked Questions

What are the latest SEC filings for Picard Medical, INC. (PMI)?

Picard Medical, INC. has 26 recent SEC filings from Apr 2025 to Apr 2026, including 14 8-K, 7 S-1/A, 2 10-Q. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of PMI filings?

Across 26 filings, the sentiment breakdown is: 2 bearish, 22 neutral, 2 mixed. The dominant sentiment is neutral.

Where can I find Picard Medical, INC. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Picard Medical, INC. (PMI) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Picard Medical, INC.?

Key financial highlights from Picard Medical, INC.'s most recent 10-K include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for PMI?

The investment thesis for PMI includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Picard Medical, INC.?

Key executives identified across Picard Medical, INC.'s filings include Patrick NJ Schnegelsberg, Bernard Skaggs, Matt Schuster, Michael J. Blankenship, Beniamin D. Smolij and 3 others.

What are the main risk factors for Picard Medical, INC. stock?

Of PMI's 19 assessed filings, 5 were flagged high-risk, 8 medium-risk, and 6 low-risk.

What are recent predictions and forward guidance from Picard Medical, INC.?

Forward guidance and predictions for Picard Medical, INC. are extracted from SEC filings as they are enriched.